115 related articles for article (PubMed ID: 9641155)
1. Goodpasture syndrome and end-stage renal failure--to transplant or not to transplant?
Netzer KO; Merkel F; Weber M
Nephrol Dial Transplant; 1998 Jun; 13(6):1346-8. PubMed ID: 9641155
[No Abstract] [Full Text] [Related]
2. Late presentation of Alport posttransplantation anti-glomerular basement membrane disease.
de Sandes-Freitas TV; Holanda-Cavalcanti A; Mastroianni-Kirsztajn G; Franco MF; Medina-Pestana JO
Transplant Proc; 2011 Dec; 43(10):4000-1. PubMed ID: 22172887
[TBL] [Abstract][Full Text] [Related]
3. Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome.
Cove-Smith JR; McLeod AA; Blamey RW; Knapp MS; Reeves WG; Wilson CB
Clin Nephrol; 1978 Mar; 9(3):126-8. PubMed ID: 346273
[TBL] [Abstract][Full Text] [Related]
4. Post-renal transplant pulmonary haemorrhage in a patient with Goodpasture syndrome without renal involvement and anti-glomerular basement membrane antibody: A case report.
Lee H; Park Y; Kang D; Eum SH; Kim Y; Yang CW; Choi YJ; Park CW
Nephrology (Carlton); 2022 Mar; 27(3):288-289. PubMed ID: 34496099
[No Abstract] [Full Text] [Related]
5. Ulcerative colitis in a renal transplant patient with previous Goodpasture disease.
Hibbs AM; Bznik-Cizman B; Guttenberg M; Goldberg B; Meyers K
Pediatr Nephrol; 2001 Jul; 16(7):543-6. PubMed ID: 11465800
[TBL] [Abstract][Full Text] [Related]
6. Goodpasture syndrome: pathophysiology, diagnosis, and management.
Fox HL; Swann D
Nephrol Nurs J; 2001 Jun; 28(3):305-10; quiz 311-2. PubMed ID: 12143452
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of Goodpasture syndrome].
Kuhn M; Gartmann J; Hartmann G
Dtsch Med Wochenschr; 1985 Feb; 110(5):183-4. PubMed ID: 3881240
[No Abstract] [Full Text] [Related]
8. Effectiveness of Plasmapheresis in a Patient with Anti-glomerular Basement Membrane Antibody Glomerulonephritis with Advanced Kidney Dysfunction.
Usui T; Kai H; Noguchi K; Morito N; Usui J; Saito C; Uesugi N; Nagata M; Yamagata K
Intern Med; 2017 Sep; 56(18):2475-2479. PubMed ID: 28824070
[TBL] [Abstract][Full Text] [Related]
9. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
10. [Anti glomerular basement membrane disease in a renal transplant patient with Alport syndrome].
Soler Pujol G; Iotti R; Dávalos Michel M; Turner AN; Vilches AR
Medicina (B Aires); 1999; 59(5 Pt 1):466-8. PubMed ID: 10684168
[TBL] [Abstract][Full Text] [Related]
11. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
McLeish KR; Maxwell DR; Luft FC
Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
[TBL] [Abstract][Full Text] [Related]
12. [Goodpasture syndrome--diagnostic problems].
Sydor A; Siudzińska J; Dubiel-Bigaj M; Plezia B; Okoń K
Przegl Lek; 2004; 61(5):523-7. PubMed ID: 15515819
[TBL] [Abstract][Full Text] [Related]
13. Goodpasture syndrome: selective removal of anti-alpha 3 (IV) collagen autoantibodies. A potential therapeutic alternative to plasmapheresis.
Boutaud AA; Kalluri R; Kahsai TZ; Noelken ME; Hudson BG
Exp Nephrol; 1996; 4(4):205-12. PubMed ID: 8864724
[TBL] [Abstract][Full Text] [Related]
14. Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome.
Erickson SB; Kurtz SB; Donadio JV; Holley KE; Wilson CB; Pineda AA
Mayo Clin Proc; 1979 Nov; 54(11):714-20. PubMed ID: 491763
[TBL] [Abstract][Full Text] [Related]
15. [Cadaveric renal transplantation for Goodpasture's syndrome: a case report].
Miyazato M; Koyama Y; Miyazato T; Yonou H; Naito A; Sugaya K; Hatano T; Ogawa Y
Hinyokika Kiyo; 2001 Jul; 47(7):493-5. PubMed ID: 11523135
[TBL] [Abstract][Full Text] [Related]
16. Resolution of hypercalcemia and aluminum bone disease after renal transplantation.
Piraino B; Carpenter BJ; Puschett JB
Am J Med; 1988 Nov; 85(5):728-30. PubMed ID: 3055982
[No Abstract] [Full Text] [Related]
17. Goodpasture's syndrome: treatment with plasmapheresis, immunosuppression, and anticoagulation.
Levin M; Rigden SP; Pincott JR; Lockwood CM; Barratt TM; Dillon MJ
Arch Dis Child; 1983 Sep; 58(9):697-702. PubMed ID: 6625631
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary: renal syndrome with a focus on anti-GBM disease.
Sanders JS; Rutgers A; Stegeman CA; Kallenberg CG
Semin Respir Crit Care Med; 2011 Jun; 32(3):328-34. PubMed ID: 21674418
[TBL] [Abstract][Full Text] [Related]
19. Outcome of renal transplantation in patients with both ANCA and anti-GBM antibodies.
Raman G; Srivastava A; Geetha D
Transplantation; 2012 Sep; 94(5):e30-1. PubMed ID: 22955170
[No Abstract] [Full Text] [Related]
20. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
